Even though most people with cystic fibrosis (CF) place considerable importance on being prepared in making decisions about a…
Articles by Marisa Wexler, MS
Genexys Biomed has been awarded a $320,000 grant to advance the development of a novel gene therapy for cystic…
The first cystic fibrosis (CF) patient has been dosed in Part A of a Phase 2 clinical trial in…
Authorities in the U.S. and Europe are reviewing applications from Vertex Pharmaceuticals seeking approval of the company’s novel CFTR…
During pulmonary exacerbation in cystic fibrosis (CF), bacterial communities in the lungs tend to change in one of two…
Two Massachusetts-based companies, Nanite and Saliogen Therapeutics, are teaming up on a new research project that aims to…
This year’s “Fishing for a Cure,” an annual fundraiser hosted by Constellation Energy Corporation, has raised $70,000 for the…
Evoq Bio said it successfully completed a meeting with the U.S. Food and Drug Administration (FDA), held to discuss the…
Phage therapy, a promising strategy for treating antibiotic-resistant lung infections that’s currently in clinical trials, can trigger the release of…
Treatment with Kaftrio (elexacaftor/tezacaftor/ivacaftor) helps increase fat stores in adults with cystic fibrosis (CF), especially those who are…